tiprankstipranks
Trending News
More News >
Vinati Organics Limited (IN:VINATIORGA)
:VINATIORGA
India Market

Vinati Organics Limited (VINATIORGA) AI Stock Analysis

Compare
1 Followers

Top Page

IN:VINATIORGA

Vinati Organics Limited

(VINATIORGA)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 5.2)
Rating:69Neutral
Price Target:
₹1,669.00
▲(4.28% Upside)
Vinati Organics Limited demonstrates strong financial performance with robust revenue growth and profitability, which is the most significant factor in the overall score. However, the high P/E ratio and modest dividend yield suggest a high valuation, which may limit immediate investment appeal. Technical indicators show a stable but non-trending market position, contributing to a moderate overall score.
Positive Factors
Strong margins and revenue growth
High margins plus near-20% revenue growth signal durable operating leverage. Sustained gross and EBITDA margins support reinvestment in capacity and R&D, enable pricing flexibility versus inputs, and underpin long-term free-cash generation if capex normalizes.
Very low financial leverage
Minimal debt and a strong equity base provide financial resilience and optionality for strategic investment. Low leverage reduces refinancing risk and interest burden, allowing management to fund capex or weather cyclical downturns without heavy external financing.
Niche specialty-chemicals business model
Specialization in technical intermediates creates high switching costs and customer qualification barriers. Long-term supply relationships with industrial customers foster recurring demand, support pricing power in niche segments, and raise barriers to new entrants.
Negative Factors
Negative free cash flow trend
Persistently negative free cash flow driven by elevated capex constrains internal funding for dividends, debt paydown or acquisitions. If capex remains high, the company may need external financing or slower growth, reducing strategic flexibility over the medium term.
Margin sensitivity to feedstock and energy costs
Profitability depends on maintaining spreads over volatile raw-material, energy and logistics costs. Structural swings in commodity or energy prices can compress margins long-term unless pass-through pricing, vertical integration or effective hedging is implemented.
Product concentration risk
Revenue reliance on a few core molecules increases exposure to demand shifts, regulatory changes or competitive displacement in those end-markets. Limited product diversification can amplify cyclicality and raise long-term revenue and margin volatility.

Vinati Organics Limited (VINATIORGA) vs. iShares MSCI India ETF (INDA)

Vinati Organics Limited Business Overview & Revenue Model

Company DescriptionVinati Organics Limited, a specialty chemical company, engages in the manufacture and sale of specialty organic intermediaries and monomers primarily in India. It offers specialty monomers comprising 2-acrylamido 2-methylpropane sulphonic acid, sodium salt of 2-acrylamido-2-methylpropane sulphonic acid, N-tertiary butyl acrylamide, and N-tertiary octyl acrylamide. The company also provides aromatics, including isobutyl benzene, which is used as raw material for manufacturing ibuprofen, an anti-inflammatory analgesic bulk drug; normal butyl benzene that is used as compound for chemical synthesis of a number of intermediates; hexenes, which is used as low boiling point solvents, as thinners, for solvent extractions, in tire retreading, as octane booster for gasoline, and for manufacturing C-5/C-6 aliphatic petroleum; and butyl phenols. In addition, it offers methyl-4-tert butyl benzoate; para tertiary butyl benzoic acid; isobutylene, a carbon branched olefin; methanol for use as a chemical intermediate; high purity methyl tertiary butyl ether that is used as a solvent in organic synthesis, pharmaceutical synthesis, and synthesis of Grignard's reagent; tertiary-butylamine; and polymers for use in industries, such as construction, ceramics, oil drilling, mining, leather, and paper. The company also exports its products primarily to the United States, Europe, and Asia. Vinati Organics Limited was incorporated in 1989 and is based in Mumbai, India.
How the Company Makes MoneyVinati Organics generates revenue primarily through the sale of specialty chemicals and intermediates used in various industries, including pharmaceuticals, agrochemicals, and plastics. The company has multiple key revenue streams, including the production and sale of its flagship products like methyl methacrylate and isobutylbenzene, which are in high demand globally. Additionally, Vinati Organics benefits from strategic partnerships and collaborations with other companies in the chemical sector, enhancing its market reach and operational efficiencies. The company's commitment to research and development also allows it to innovate and introduce new products, contributing to its overall earnings and market competitiveness.

Vinati Organics Limited Financial Statement Overview

Summary
Vinati Organics Limited exhibits strong financial performance with robust revenue growth and profitability, supported by a stable balance sheet with low leverage. Despite challenges in free cash flow due to high capital expenditures, the company maintains healthy operational cash flow. Overall, the financial health is robust, with potential for continued growth and expansion.
Income Statement
85
Very Positive
Vinati Organics Limited demonstrates a robust income statement with strong revenue growth and profitability. The gross profit margin for 2025 is approximately 40.1%, indicating efficient cost management. The net profit margin has also improved to 18%, reflecting enhanced profitability. Notably, the revenue growth rate from 2024 to 2025 is 18.9%, showcasing significant business expansion. Additionally, the EBIT and EBITDA margins stand at 33.9% and 25.8%, respectively, highlighting strong operational efficiency.
Balance Sheet
78
Positive
The balance sheet of Vinati Organics Limited is stable with a low debt-to-equity ratio of 0.02, indicating minimal leverage and reduced financial risk. The return on equity (ROE) for 2025 is 14.5%, showing effective utilization of shareholder funds to generate profits. The equity ratio is high at 85.2%, reflecting a strong capital structure with a significant portion of assets financed by equity. Overall, the balance sheet suggests financial stability and low risk.
Cash Flow
70
Positive
Cash flow analysis reveals a mixed scenario. The free cash flow has significantly declined from -719.1 million in 2024 to -420.5 million in 2025, but the operating cash flow to net income ratio is favorable at 1.13, indicating good cash generation from operations relative to net income. However, the free cash flow to net income ratio is negative due to high capital expenditures, suggesting potential constraints on cash availability for investment and expansion.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue22.65B22.36B18.90B20.65B16.13B9.42B
Gross Profit9.27B9.01B5.49B10.01B7.52B5.55B
EBITDA6.52B5.81B5.10B6.25B4.96B3.79B
Net Income4.25B4.05B3.23B4.19B3.47B2.69B
Balance Sheet
Total Assets0.0032.79B28.40B25.47B20.90B17.34B
Cash, Cash Equivalents and Short-Term Investments139.30M139.30M333.80M2.03B142.48M1.88B
Total Debt0.00626.30M46.46M2.01M183.99M20.25M
Total Liabilities-27.93B4.86B3.82B3.29B2.62B1.90B
Stockholders Equity27.93B27.93B24.62B22.18B18.28B15.43B
Cash Flow
Free Cash Flow0.00-420.50M-719.14M2.99B-471.06M1.36B
Operating Cash Flow0.004.58B3.32B5.77B1.27B2.19B
Investing Cash Flow0.00-4.43B-3.48B-3.67B-2.55B-1.98B
Financing Cash Flow0.00-155.80M-1.08B-859.60M-465.42M-30.98M

Vinati Organics Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1600.55
Price Trends
50DMA
1573.91
Negative
100DMA
1632.35
Negative
200DMA
1714.80
Negative
Market Momentum
MACD
-22.45
Positive
RSI
38.76
Neutral
STOCH
22.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VINATIORGA, the sentiment is Negative. The current price of 1600.55 is above the 20-day moving average (MA) of 1558.25, above the 50-day MA of 1573.91, and below the 200-day MA of 1714.80, indicating a bearish trend. The MACD of -22.45 indicates Positive momentum. The RSI at 38.76 is Neutral, neither overbought nor oversold. The STOCH value of 22.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VINATIORGA.

Vinati Organics Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
₹157.98B35.670.48%8.96%17.70%
64
Neutral
₹182.97B30.790.41%16.46%43.59%
64
Neutral
₹312.33B68.720.23%30.05%70.18%
62
Neutral
₹134.76B46.300.26%8.26%-34.62%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
59
Neutral
₹157.67B42.030.51%0.43%-42.29%
52
Neutral
₹223.91B42.130.44%-7.50%-37.67%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:VINATIORGA
Vinati Organics Limited
1,523.95
-217.22
-12.48%
IN:AARTIIND
AARTI Industries Ltd
371.65
-79.55
-17.63%
IN:ATUL
Atul Limited
6,214.60
61.66
1.00%
IN:BASF
BASF India Limited
3,642.45
-582.47
-13.79%
IN:DEEPAKNTR
Deepak Nitrite Limited
1,641.65
-678.40
-29.24%
IN:NAVINFLUOR
Navin Fluorine International Limited
6,095.25
1,933.40
46.46%

Vinati Organics Limited Corporate Events

Vinati Organics Publishes Q2 Financial Results
Nov 6, 2025

Vinati Organics Limited announced the publication of its unaudited standalone and consolidated financial results for the second quarter and half-year ending September 30, 2025. These results were approved by the Board of Directors and published in compliance with SEBI regulations. The publication, which includes a Quick Response code for accessing complete financial details, reflects the company’s commitment to transparency and regulatory compliance, potentially impacting its market perception and stakeholder confidence.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 02, 2025